| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.24 | 1e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.2 | 0.0009 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |